ESC 365 - Contemporary use of SGLT2i therapy among patients hospitalized for heart failure with reduced ejection fraction in the United States

HFA Premium Access

Contemporary use of SGLT2i therapy among patients hospitalized for heart failure with reduced ejection fraction in the United States

Session: Chronic heart failure - pathophysiology and mechanisms 1

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Professor S. Greene (Durham, US)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Professor Stephen Greene

Duke Clinical Research Institute, Durham (United States of America)

10 presentations

2 followers

7 more presentations in this session

Right ventricular function and coupling to the pulmonary circulation in heart failure with preserved ejection fraction: the PARAGON-HF trial

Speaker: Doctor R. Inciardi (Brescia, IT)

Achieved heart rate of less than 70 beats per minute after ivabradine treatment is related to left ventricular reverse remodeling in idiopathic dilated cardiomyopathy

Speaker: Ms J. Lee (Seoul, KR)

Role of aldosterone in long-term left ventricular remodelling after acute myocardial infarction: the REMI study

Speaker: Doctor L. Monzo (Vandoeuvre-Les-Nancy, FR)

Cardiac reverse remodeling in real life, a therapeuthic objective.

Speaker: Miss C. Otte Alba (Sevilla, ES)

Effect of sacubitril/valsartan on cardiac remodeling compared with other renin-angiotensin-system inhibitors: a difference-in-difference analysis of propensity score matched samples

Speaker: Doctor S. Sforna (Perugia, IT)

Access the full session

Chronic heart failure - pathophysiology and mechanisms 1

Speakers: Professor S. Greene, Doctor R. Inciardi, Ms J. Lee, Doctor L. Monzo, Miss C. Otte Alba...

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources